Dawei Zhang
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Oncology top 10%
- Viral-associated cancers and disorders
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Glycosylation and Glycoproteins Research 3
- Oncology 19
- Peptidase Inhibition and Analysis 6
- Viral-associated cancers and disorders 4
- Lung Cancer Research Studies 3
- Co-authors
- Yuan Mao (14 shared papers)Jin Zhu (11 shared papers)Lin Xiong (11 shared papers)Dong Ji (1 shared paper)Peng Zhao (1 shared paper)George Lau (1 shared paper)Guofeng Chen (1 shared paper)Lin Tan (1 shared paper)
- Journals
- Scientific Reports (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Pathology (2 papers)Diagnostic Pathology (1 paper)Anti-Cancer Agents in Medicinal Chemistry (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Dawei Zhang
70 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 112
- Infectious Diseases 241
- Oncology 325
- Pathology and Forensic Medicine 152
- Immunology 129
- Radiology, Nuclear Medicine and Imaging 131
Countries citing papers authored by Dawei Zhang
This map shows the geographic impact of Dawei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawei Zhang more than expected).
Fields of papers citing papers by Dawei Zhang
This network shows the impact of papers produced by Dawei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawei Zhang. The network helps show where Dawei Zhang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dawei Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 397 | |
| 2 | 2014 | 97 | |
| 3 | 2013 | 82 | |
| 4 | 2011 | 41 | |
| 5 | 2012 | 39 | |
| 6 | 2012 | 38 | |
| 7 | 2014 | 36 | |
| 8 | 2011 | 34 | |
| 9 | 2014 | 32 | |
| 10 | 2016 | 28 | |
| 11 | 2016 | 27 | |
| 12 | Upregulated TIMP-1 correlates with poor prognosis of laryngeal squamous cell carcinoma. | 2014 | 27 |
| 13 | 2013 | 25 | |
| 14 | 2017 | 24 | |
| 15 | 2012 | 22 | |
| 16 | 2012 | 20 | |
| 17 | 2020 | 20 | |
| 18 | 2016 | 18 | |
| 19 | 2020 | 17 | |
| 20 | 2024 | 17 |
About Dawei Zhang
Dawei Zhang is a scholar working on Molecular Biology, Oncology, Pathology and Forensic Medicine, Surgery and Pulmonary and Respiratory Medicine, having authored 74 papers that have together received 1.3k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (6 papers), Lymphoma Diagnosis and Treatment (6 papers), Neuroblastoma Research and Treatments (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Viral-associated cancers and disorders (4 papers), Glycosylation and Glycoproteins Research (3 papers), Tumors and Oncological Cases (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Infectious Diseases (241 citations), Oncology (325 citations), Pathology and Forensic Medicine (152 citations), Immunology (129 citations) and Radiology, Nuclear Medicine and Imaging (131 citations). Dawei Zhang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yuan Mao, Jin Zhu, Lin Xiong, Dong Ji, Peng Zhao, George Lau, Guofeng Chen, Lin Tan, Jingfeng Bi and Enqiang Qin. Their work appears in journals such as Scientific Reports, Bioorganic & Medicinal Chemistry Letters, Pathology, Diagnostic Pathology and Anti-Cancer Agents in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.